T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients

Psychiatry Research

Volumn 129, Issue 3, 2004, Pages 267-272

  Kim, Yong Ku ^a   Myint, Aye Mu ^b,c   Lee, Bun Hee ^a   Han, Chang Su ^a   Lee, Seung Whan ^d   Leonard, Brian E ^b,e   Steinbusch, Harry W M ^b  

^a Korea University College of Medicine   (South Korea)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d Inje University   (South Korea)

^e NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Bipolar disorder; Cytokine; Interferon; Interleukin; Lithium; TGF

Indexed keywords

CLOZAPINE; CYTOKINE; GAMMA INTERFERON; HALOPERIDOL; INTERLEUKIN 4; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; TRANSFORMING GROWTH FACTOR BETA1; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HELPER CELL; HOSPITAL ADMISSION; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MANIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 12344336389     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2004.08.005     Document Type: Article

References (27)

1. K. Akiyama Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration Schizophrenia Research 37 1999 97 106
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 Author Washington, DC
3. M. Barral-Netto, A. Barral, C.E. Brownell, Y.A. Skeiky, L.R. Ellingsworth, D.R. Twardzik, and S.G. Reed Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism Science 257 1992 545 548
4. M.N. Breunis, R.W. Kupka, W.A. Nolen, T. Suppes, K.D. Denicoff, G.S. Leverich, R.M. Post, and H.A. Drexhage High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder Biological Psychiatry 53 2003 157 165
5. D.F. Darko, J.C. Gillin, S.C. Risch, K. Bulloch, S. Golshan, Z. Tasevska, and R.N. Hamburger Mitogen-stimulated lymphocyte proliferation and pituitary hormones in major depression Biological Psychiatry 26 1989 145 155
6. D.F. Darko, J.C. Gillin, S.G. Risch, S. Golshan, K. Bulloch, and S.M. Baird Peripheral white blood cells and HPA axis neurohormones in major depression International Journal of Neuroscience 45 1989 153 159
7. F. Erard, J.A. Garcia-Sanz, R. Moriggl, and M.T. Wild Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets Journal of Immunology 162 1999 209 214
8. M. First, R.L. Spitzer, and GibbonM. Williams Structured Clinical Interview for DSM-IV Axis I Disorder-Patient Edition (SCID-I/P, version 2.0) 1998 Biometrics Research Department, New York State Psychiatric Institute New York
9. Y.K. Kim, L. Kim, and M.S. Lee Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics Schizophrenia Research 44 2000 165 175
10. Y.K. Kim, I.B. Suh, H. Kim, C.S. Han, C.S. Lim, S.H. Choi, and J. Licinio The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs Molecular Psychiatry 7 2002 1107 1114
11. J.J. Letterio, and A.B. Roberts TGF-beta: a critical modulator of immune cell function Clinical Immunology and Immunopathology 84 1997 244 250
12. M. Maes, E. Bosmans, J. Calabrese, R. Smith, and H.Y. Meltzer Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers Journal of Psychiatric Research 29 1995 141 152
13. M. Maes, H.Y. Meltzer, P. Buckley, and E. Bosmans Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression European Archives of Psychiatry and Clinical Neuroscience 244 1995 325 329
14. K. Miyazono, K. Yuki, F. Takaku, C. Wernstedt, T. Kanzaki, A. Olofsson, U. Hellman, and C.H. Heldin Latent forms of TGF-beta: structure and biology Annals of the New York Academy of Sciences 593 1990 51 58
15. J.E. Overall, and D.R. Gorham The Brief Psychiatric Rating Scale Psychological Reports 10 1962 799 812
16. G.J. Prud'homme, and C.A. Piccirillo The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases Journal of Autoimmunity 14 2000 23 42
17. M.H. Rapaport, and H.K. Manji The effects of lithium on ex vivo cytokine production Biological Psychiatry 50 2001 217 224
18. M.H. Rapaport, L. Guylai, and P. Whybrow Immune parameters in rapid cycling bipolar patients before and after lithium treatment Journal of Psychiatric Research 33 1999 335 340
19. J. Schlatter, F. Ortuno, and S. Cervera-Enguix Differences in interleukins' patterns between dysthymia and major depression European Psychiatry 16 2001 317 319
20. + T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta European Journal of Immunology 24 1994 793 798
21. + natural killer cells and related cytokines in major depression Clinical Immunology and Immunopathology 78 1996 83 85
22. W. Strober, B. Kelsall, I. Fuss, T. Marth, B. Ludviksson, R. Ehrhardt, and M. Neurath Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation Immunology Today 18 1997 61 64
23. K.P. Su, S.J. Leu, Y.Y. Yang, W.W. Shen, Y.M. Chou, and S.Y. Tsai Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission Journal of Affective Disorders 71 2002 205 209
24. S.Y. Tsai, K.P. Chen, Y.Y. Yang, C.C. Chen, J.C. Lee, V.K. Singh, and S.J. Leu Activation of indices of cell-mediated immunity in bipolar mania Biological Psychiatry 45 1999 989 994
25. S.Y. Tsai, Y.Y. Yang, C.J. Kuo, C.C. Chen, and S.J. Leu Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania Journal of Affective Disorders 64 2001 185 193
26. F. Villemain, L. Chatenoud, E. Guillibert, Y. Pelicier, and J.F. Bach Decreased production of interleukin-2 in schizophrenia Annals of the New York Academy of Sciences 496 1987 669 675
27. R.C. Young, J.T. Biggs, V.E. Ziegler, and D.A. Meyer A rating scale for mania: reliability, validity and sensitivity British Journal of Psychiatry 133 1978 429 435